OrbusNeich Medical Group Limited, a Hong Kong-based firm that develops medical devices for vascular intervention, has secured $200 million in two funding rounds to double down on its new and existing product development in Greater China and worldwide.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
